Back to WELLINGTON MANAGEMENT GROUP LLP

XENE
Showing 8 of 13 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLP's holdings in XENON PHARMACEUTICALS INC

WELLINGTON MANAGEMENT GROUP LLP holds 4.8M shares of XENE (XENON PHARMACEUTICALS INC), worth $280.8M as of 2026-Q1. The position was increased (+1.4% shares). XENE represents 0.1% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$280.8M

Current Shares

4.8M

Total Value Change

+$131.6M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
4.8M
+1.4%
$280.8M0.1%$43.79
31
2025-Q4
Increased
4.8M
+32.0%
$213.6M0.0%$44.12
39
2025-Q3
Increased
3.6M
+66.0%
$144.9M0.0%$39.06
44
2025-Q2
Decreased
2.2M
-42.6%
$68.1M0.0%$32.40
0
2025-Q1
Increased
3.8M
+0.3%
$127.1M0.0%$34.26
30
2024-Q4
Decreased
3.8M
-1.7%
$148.1M0.0%$38.53
0
2024-Q3
Increased
3.8M
+0.4%
$151.3M0.0%$38.65
30
2024-Q2
Decreased
3.8M
-2.4%
$149.3M0.0%$38.99
0

Other major holders of XENE: FMR LLC, Avoro Capital Advisors LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used